Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kolkhof, Peter
157  Ergebnisse:
Personensuche X
?
1

Single-cell transcriptomics and chromatin accessibility pro..:

Abedini, Amin ; Sánchez-Navaro, Andrea ; Wu, Junnan...
Journal of Clinical Investigation.  134 (2024)  1 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
2

Finerenone in Black Patients With Type 2 Diabetes and CKD: ..:

Flack, John M. ; Agarwal, Rajiv ; Anker, Stefan D....
Kidney Medicine.  5 (2023)  12 - p. 100730 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Finerenone, a Non-Steroidal Mineralocorticoid Receptor Anta..:

Jerome, Jack R. ; Deliyanti, Devy ; Suphapimol, Varaporn..
International Journal of Molecular Sciences.  24 (2023)  3 - p. 2334 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Front Cover:

Perakakis, Nikolaos ; Bornstein, Stefan R. ; Birkenfeld, Andreas L....
Diabetes, Obesity and Metabolism.  26 (2023)  1 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
5

Cardiorenal Outcomes with Finerenone in Asian Patients with..:

Koya, Daisuke ; Anker, Stefan D. ; Ruilope, Luis M....
American Journal of Nephrology.  54 (2023)  9-10 - p. 370-378 , 2023
Link: https://doi.org/10.1159/..
 
?
6

Benefits of the Non-Steroidal Mineralocorticoid Receptor An..:

Lima-Posada, Ixchel ; Stephan, Yohan ; Soulié, Matthieu...
International Journal of Molecular Sciences.  24 (2023)  3 - p. 2536 , 2023
Link: https://doi.org/10.3390/..
 
?
7

Efficacy of finerenone in patients with type 2 diabetes, ch..:

Perakakis, Nikolaos ; Bornstein, Stefan R. ; Birkenfeld, Andreas L....
Diabetes, Obesity and Metabolism.  26 (2023)  1 - p. 191-200 , 2023
Link: https://doi.org/10.1111/..
 
?
8

Rationale and design of a randomised phase III registration..:

Heerspink, Hiddo J.L. ; Birkenfeld, Andreas L. ; Cherney, David Z.I....
Diabetes Research and Clinical Practice.  204 (2023)  - p. 110908 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Novel non‐steroidal mineralocorticoid receptor antagonists ..:

Kintscher, Ulrich ; Bakris, George L. ; Kolkhof, Peter
British Journal of Pharmacology.  179 (2022)  13 - p. 3220-3234 , 2022
Link: https://doi.org/10.1111/..
 
?
10

Finerenone and Heart Failure Outcomes by Kidney Function/Al..:

Filippatos, Gerasimos ; Anker, Stefan D. ; Pitt, Bertram...
JACC: Heart Failure.  10 (2022)  11 - p. 860-870 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Finerenone in patients with chronic kidney disease and type..:

Filippatos, Gerasimos ; Pitt, Bertram ; Agarwal, Rajiv...
European Journal of Heart Failure.  24 (2022)  6 - p. 996-1005 , 2022
Link: https://doi.org/10.1002/..
 
?
12

Finerenone Reduces Risk of Incident Heart Failure in Patien..:

Filippatos, Gerasimos ; Anker, Stefan D. ; Agarwal, Rajiv...
Circulation.  145 (2022)  6 - p. 437-447 , 2022
Link: https://doi.org/10.1161/..
 
?
13

Molecular mechanisms and therapeutic targets for diabetic k..:

Tuttle, Katherine R. ; Agarwal, Rajiv ; Alpers, Charles E....
Kidney International.  102 (2022)  2 - p. 248-260 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Finerenone in Mild to Severe Chronic Kidney Disease and Typ..:

Filippatos, Gerasimos ; Agarwal, Rajiv ; Anker, Stefan D....
American Heart Journal.  254 (2022)  - p. 254 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Finerenone efficacy in patients with chronic kidney disease..:

Filippatos, Gerasimos ; Anker, Stefan D ; Pitt, Bertram...
European Heart Journal - Cardiovascular Pharmacotherapy.  9 (2022)  1 - p. 85-93 , 2022
Link: https://doi.org/10.1093/..
 
1-15